Navigation Links
Hepatitis E research receives funding
Date:10/17/2010

Researchers from the Royal Cornwall Hospital in Truro have received a grant of 337,000 to carry out a two-year study with partners in Glasgow and Norwich into a rare form of Hepatitis - Hepatitis E. The grant has come from the Chief Scientist's Office for Scotland and will be divided between the three centres taking part in the study.

Dr Harry Dalton, a Consultant Gastroenterologist at the Royal Cornwall Hospitals Trust and affiliate member of the Peninsula College of Medicine and Dentistry's European Centre for Environment and Human Health (ECEHH), will be leading a team in Cornwall. Dr Dalton and his team in Truro have been involved in developing tests to diagnose Hepatitis E, and they are regarded as one of the world leaders in this condition. In fact an unusual strain of the virus, which was found in a patient in the Cornish Centre, was sent to the National Institutes of Health in Maryland, USA. They sequenced the viral genome and it has been named Kernow C1.

Dr Dalton said: "This came about in Cornwall because I run a jaundice clinic twice a week. We had a small proportion of patients and we couldn't work out what was wrong with them and that's when we discovered it was Hepatitis E."

Hepatitis E is an infection which is normally associated with developing countries such as India, Central Africa and Nepal and is generally thought to be caused by poor sanitary conditions. Previously it had always been assumed that in countries like Britain if Hepatitis E showed up it was in people who had travelled abroad. However, that was proving to not be the situation in many cases found in Cornwall and the rest of the UK.

Dr Dalton said: "Not only had the patients not travelled abroad but they didn't fit the normal age range for the virus. In other parts of the world it usually affects the young and they usually get over it. However, in the cases being seen in the UK it is the middle aged and elderly, particularly men, who are getting
'/>"/>

Contact: Andrew Gould
andrew.gould@pms.ac.uk
44-139-268-6107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. First clinical trials successfully completed on potent new hepatitis C drug
2. New antiviral drug shows promise for dramatic improvement in hepatitis C treatment
3. New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment
4. Tattooing linked to higher risk of hepatitis C: UBC study
5. Misuse of anesthesia could cause hepatitis virus transmission
6. Depression overlooked in patients with hepatitis C; compromising HCV therapy
7. Silencing hepatitis B virus prevent recurrence of liver cancer
8. Success of Hepatitis C Drugs May Depend on Gene Variant
9. New study confirms link between nonalcoholic steatohepatitis and liver cancer
10. EU gives green light for while-you-wait hepatitis B test
11. Trials begin on potent new hepatitis C drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Hamilton Facial Plastic Surgery is happy ... on July 30th. After months of planning, Dr. Hamilton ... state-of-the-art suite, located only steps away from the original ... one-on-one patient comfort, shorter wait times, and generally a ... new office-suite will continue to provide the same wide ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 DRE Medical ... to announce the launch of its Medical Trade ... resource for medical professionals and equipment vendors. , The ... and conventions in the United States and around the ... calendar, and that number is always growing. , Information ...
(Date:7/30/2014)... The Technology Association of Georgia in ... (B&TA), today issued its final call for applications and ... companies have until August 29th 2014 to be considered ... selected by the Excalibur Judging Committee. Companies selected as ... judges for interviewing process. , The TAG Excalibur ...
(Date:7/30/2014)... LTC Consumer, an independent, free online service to help consumers ... Quote tool on its website, LTCconsumer.com , announced Nathan ... free and unlimited. , The Instant Quote tool ... age, gender, and state of residence – and delivers a ... enter any contact information to get started). There is no ...
(Date:7/30/2014)... Detroit, MI (PRWEB) July 30, 2014 ... community to celebrate Safety Day from 4 p.m. to ... in Livonia (29580 7 Mile Road, Livonia, MI 48152). ... DeKeyser, free bike helmets, children’s activities, music, snacks and ... for $299,497 to the Children’s Hospital of Michigan Foundation. ...
Breaking Medicine News(10 mins):Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:DRE Launches Online Interactive Medical Trade Show Calendar 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 3Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 3Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 4
... ... it experiences a significant increase in calls in 2009 , ... Belleville, Ill. (Vocus) July 26, 2009 -- Allsup has awarded ... national nonprofit organization,s Information HelpLine, which is experiencing a dramatic increase in calls from individuals ...
... KIGALI, Rwanda (July 27, 2009) Government health officials ... for accreditation of the continent,s medical laboratories, starting a ... U.S. Government believe will be an historic step to ... patients. Just a handful of Africa,s laboratories are ...
... but long-term use raises concerns , SUNDAY, July 26 ... be given to children apparently depends on who you ... have recommended that obese children as young as 8 ... lifestyle changes don,t improve their health. , , But ...
... , , WASHINGTON, July 25 ... Landrieu today made the following comment on the release of the ... on Small Businesses and Their Employees" report: , ... to address concerns of small businesses and healthcare -- the number ...
... 24 Duane Reade Holdings, Inc. announced today that its ... "Issuers"), have amended the terms of their previously announced offers ... Notes due 2010 (the "Floating Rate Notes") (the "FRN Offer") ... "Subordinated Notes" and, together with the Floating Rate Notes, the ...
... could speed repair of ligaments, tendons, study shows , FRIDAY, ... University undergraduates say they have found a way to quickly ... a procedure they believe may help improve healing and prevent ... procedure as part of a contest sponsored by a medical ...
Cached Medicine News:Health News:Allsup Awards Grant to National Alliance on Mental Illness 2Health News:Allsup Awards Grant to National Alliance on Mental Illness 3Health News:Leading health organizations launch new accreditation process for laboratories across Africa 2Health News:Leading health organizations launch new accreditation process for laboratories across Africa 3Health News:Leading health organizations launch new accreditation process for laboratories across Africa 4Health News:Giving Statins to Kids Provokes Debate 2Health News:Giving Statins to Kids Provokes Debate 3Health News:Duane Reade Holdings, Inc. Amends Terms and Extends Deadlines for Previously Announced Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes 2Health News:Duane Reade Holdings, Inc. Amends Terms and Extends Deadlines for Previously Announced Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes 3Health News:Duane Reade Holdings, Inc. Amends Terms and Extends Deadlines for Previously Announced Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes 4Health News:Duane Reade Holdings, Inc. Amends Terms and Extends Deadlines for Previously Announced Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes 5Health News:Coming Soon -- Stem-Cell Surgical Thread? 2
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... July 30, 2014  DigiPath, Inc. (OTCBB and OTCQB: ... into the cannabis testing and education markets, announced today ... and affairs not previously disclosed or, to its knowledge, ... market action. "We have noticed unusual price ... three trading days," said Steve Barbee , CEO ...
(Date:7/30/2014)... Coordinators, Inc. (PCI) is pleased to announce it has ... Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug development ... manufacturing, as well as Clinical Packaging, Labeling, and global ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5
... 19, 2011 Families of Spinal Muscular Atrophy announced today ... and Drug Administration to commence a Phase I safety study ... being developed for Spinal Muscular Atrophy. FSMA ... stages of drug development, when risk is the highest.  It ...
... PRNewswire / -- Silicon Valley Bank ... companies worldwide, released a study today that ... capital-backed biotech and medical device companies. Based ... of US venture-capital backed companies (60 biotech and 58 ...
Cached Medicine Technology:Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA 2Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA 3Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device 2Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device 3
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Medicine Products: